IP Verse

"Chimeric Molecules And Uses Thereof" - EP3601367

The patent EP3601367 was granted to The University OF Queensland on Oct 9, 2024. The application was originally filed on Mar 29, 2018 under application number EP18775234A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3601367

THE UNIVERSITY OF QUEENSLAND
Application Number
EP18775234A
Filing Date
Mar 29, 2018
Status
Granted And Under Opposition
Sep 6, 2024
Grant Date
Oct 9, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEMay 14, 2025CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (122) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONAU20170901152-
DESCRIPTIONEP20030291813-
DESCRIPTIONEP0399843
DESCRIPTIONEP0787180
DESCRIPTIONEP1216053
DESCRIPTIONUS2003044773
DESCRIPTIONUS2003194801
DESCRIPTIONUS2004029106
DESCRIPTIONUS2005118643
DESCRIPTIONUS2005238646
DESCRIPTIONUS2006088937
DESCRIPTIONUS2006159704
DESCRIPTIONUS2006177819
DESCRIPTIONUS2007036757
DESCRIPTIONUS2007110724
DESCRIPTIONUS2008254008
DESCRIPTIONUS2009088398
DESCRIPTIONUS2009148936
DESCRIPTIONUS2009175897
DESCRIPTIONUS2009305344
DESCRIPTIONUS2010008889
DESCRIPTIONUS2010184832
DESCRIPTIONUS2010297167
DESCRIPTIONUS2011003884
DESCRIPTIONUS2011014229
DESCRIPTIONUS2011135686
DESCRIPTIONUS2012100606
DESCRIPTIONUS2012128713
DESCRIPTIONUS2012283318
DESCRIPTIONUS2012294889
DESCRIPTIONUS2013096182
DESCRIPTIONUS2013243812
DESCRIPTIONUS2014037585
DESCRIPTIONUS2014044684
DESCRIPTIONUS2014155469
DESCRIPTIONUS2014248305
DESCRIPTIONUS2014248306
DESCRIPTIONUS2014271708
DESCRIPTIONUS2014335607
DESCRIPTIONUS2015024003
DESCRIPTIONUS2015050243
DESCRIPTIONUS2015065562
DESCRIPTIONUS2015093831
DESCRIPTIONUS2015203870
DESCRIPTIONUS2015224209
DESCRIPTIONUS2015231226
DESCRIPTIONUS4331647
DESCRIPTIONUS4816567
DESCRIPTIONUS4946778
DESCRIPTIONUS5168062
DESCRIPTIONUS5225539
DESCRIPTIONUS5340740
DESCRIPTIONUS5385839
DESCRIPTIONUS5443964
DESCRIPTIONUS5545806
DESCRIPTIONUS5569825
DESCRIPTIONUS5656479
DESCRIPTIONUS5693762
DESCRIPTIONUS5698530
DESCRIPTIONUS5801030
DESCRIPTIONUS5804413
DESCRIPTIONUS5814318
DESCRIPTIONUS5821337
DESCRIPTIONUS5830510
DESCRIPTIONUS5837511
DESCRIPTIONUS5837532
DESCRIPTIONUS5846782
DESCRIPTIONUS5849561
DESCRIPTIONUS5849572
DESCRIPTIONUS5859205
DESCRIPTIONUS5869619
DESCRIPTIONUS5877397
DESCRIPTIONUS6114168
DESCRIPTIONUS6143290
DESCRIPTIONUS6372223
DESCRIPTIONUS6500668
DESCRIPTIONUS6596535
DESCRIPTIONUS6703199
DESCRIPTIONUS6855317
DESCRIPTIONUS6881557
DESCRIPTIONUS6936257
DESCRIPTIONUS6998252
DESCRIPTIONUS7029678
DESCRIPTIONUS7064244
DESCRIPTIONUS7125717
DESCRIPTIONUS7186699
DESCRIPTIONUS7247615
DESCRIPTIONUS7368116
DESCRIPTIONUS7378087
DESCRIPTIONUS7465583
DESCRIPTIONUS7550296
DESCRIPTIONUS7790449
DESCRIPTIONUS7803622
DESCRIPTIONUS8409842
DESCRIPTIONUS8637255
DESCRIPTIONUS8679837
DESCRIPTIONWO0076310
DESCRIPTIONWO03043415
DESCRIPTIONWO03076601
DESCRIPTIONWO2005042728
DESCRIPTIONWO2005694879
DESCRIPTIONWO2007006939
DESCRIPTIONWO2010066740
DESCRIPTIONWO2014140083
DESCRIPTIONWO9102788
DESCRIPTIONWO9604394
DESCRIPTIONWO9712986
DESCRIPTIONWO9815637
DESCRIPTIONWO9824838
DESCRIPTIONWO9853087
DESCRIPTIONWO9906583
INTERNATIONAL-SEARCH-REPORTWO0104335
INTERNATIONAL-SEARCH-REPORTWO2014079842
INTERNATIONAL-SEARCH-REPORTWO2015177312
INTERNATIONAL-SEARCH-REPORTWO2018027252
OPPOSITIONWO2011008974
OPPOSITIONWO2013044203
OPPOSITIONWO2014024024
OPPOSITIONWO2015018806
OPPOSITIONWO2015177312
OPPOSITIONWO2023187743
SEARCHWO2014140083

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- D6-
OPPOSITION- Jaberolansar Noushin, "Epitope-focused vaccines against respiratory syncytial virus", Doctoral Thesis, The University of Queensland, (20170101), XP093297305-
OPPOSITION- Harrison Stephen C, "Viral membrane fusion", Nature Structural & Molecular Biology, Nature Publishing Group US, New York, New York , (20080701), vol. 15, no. 7, doi:10.1038/nsmb.1456, ISSN 1545-9993, pages 690 - 698, XP037066000
OPPOSITION- Yao Yao, Kadam Rameshwar U, Lee Chang-Chun David, Woehl Jordan L, Wu Nicholas C, Zhu Xueyong, Kitamura Seiya, Wilson Ian A, Wolan Dennis W, "An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen", Proceedings of the National Academy of Sciences - PNAS, National Academy of Sciences, doi:10.1073/pnas.2006893117, (20200804), pages 18431 - 18438, Proceedings of the National Academy of Sciences - PNAS, URL: https://www.pnas.org/content/pnas/117/31/18431.full.pdf, (20210510), XP055802938
OPPOSITION- TAN KEMIN ET AL, "Atomic structure of a thermostable subdomain of HIV-1 gp41.", Proceedings of the National Academy of Sciences (PNAS), National Academy of Sciences, (19971111), vol. 94, no. 23, doi:10.1073/pnas.94.23.12303, ISSN 0027-8424, pages 12303 - 12308, XP002170631
OPPOSITION- Van Dongen Maria J. P., Kadam Rameshwar U., Juraszek Jarek, Lawson Edward, Brandenburg Boerries, Schmitz Frederike, Schepens Wim B. G., Stoops Bart, Van Diepen Harry A., Jongeneelen Mandy, Tang Chan, Vermond Jan, Van Eijgen-Obregoso Real Alida, Blokland Sven, Garg Divita, Yu Wenli, Goutier Wouter, Lanckacker Ellen, Klap Jaco M., Peeters Daniëlle C. G., Wu Jin, Buyck Christophe, Jonckers Tim H. M., Roymans Dirk, Roevens Peter, Vogels Ronald, Koudstaal Wouter, Friesen Robert H. E., Raboisson Pierre, Dhanak Dashyant, Goudsmit Jaap, Wilson Ian A., "A small-molecule fusion inhibitor of influenza virus is orally active in mice", Science - Author Manuscript, American Association for the Advancement of Science, US, US , (20190308), vol. 363, doi:10.1126/science.aar6221, ISSN 0036-8075, pages 1 - 10, XP055784681
OPPOSITION- Leen Mathys;Jan Balzarini, "The role of N-glycans of HIV-1 gp41 in virus infectivity and susceptibility to the suppressive effects of carbohydrate-binding agents", RETROVIROLOGY, BIOMED CENTRAL LTD., LONDON, GB, GB , (20141211), vol. 11, no. 1, doi:10.1186/s12977-014-0107-7, ISSN 1742-4690, page 107, XP021207589
OPPOSITION- Wijesundara Danushka K., Avumegah Michael S., Lackenby Julia, Modhiran Naphak, Isaacs Ariel, Young Paul R., Watterson Daniel, Chappell Keith J., "Rapid Response Subunit Vaccine Design in the Absence of Structural Information", Frontiers in Immunology, (20201104), vol. 11, doi:10.3389/fimmu.2020.592370, pages 1 - 8, XP055910309
SEARCH- JOSHUA DOYLE ET AL, "Two Domains That Control Prefusion Stability and Transport Competence of the Measles Virus Fusion Protein", JOURNAL OF VIROLOGY, US, (20060201), vol. 80, no. 3, doi:10.1128/JVI.80.3.1524-1536.2006, ISSN 0022-538X, pages 1524 - 1536, XP055720958 [X] 1-20 * abstract * * page 1528; figure 1 * * page 1530; figure 2A *
SEARCH- LANYING DU ET AL, "A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection", PLOS ONE, (20130108), vol. 8, no. 1, doi:10.1371/journal.pone.0053568, page e53568, XP055271141 [A] 1-20 * abstract * * page 2, column r, paragraph l - page 6, column l, line 2 * * figure 4 *
SEARCH- GUILLAUME B. E. STEWART-JONES ET AL, "A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus", PLOS ONE, (20150622), vol. 10, no. 6, doi:10.1371/journal.pone.0128779, page e0128779, XP055383379 [A] 1-20 * abstract * * page 7; figure 2 * * page 8, paragraph l * * page 12, paragraph l - page 13, paragraph 3 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents